{"id":2861,"date":"2026-08-21T20:16:46","date_gmt":"2026-08-21T19:16:46","guid":{"rendered":"https:\/\/seamlessbio.de\/?p=2861"},"modified":"2026-08-21T20:16:48","modified_gmt":"2026-08-21T19:16:48","slug":"normal-serum-ihc-if-blocking-guide","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/normal-serum-ihc-if-blocking-guide\/","title":{"rendered":"Normal Serum for IHC & IF Blocking"},"content":{"rendered":"

<\/p>\n

August 2026 \u00b7 6 min read<\/em><\/p>\n

Blocking serum selection is one of those protocol details that gets copied from paper to paper without much thought \u2014 until you get high background that you cannot explain. The species of blocking serum matters. The concentration matters. The heat inactivation matters. Here is the complete guide.<\/p>\n

Why blocking serum works \u2014 the mechanism<\/h2>\n

Non-specific background in IHC and immunofluorescence comes primarily from two sources:<\/p>\n

    \n
  1. Fc receptor binding:<\/strong> Secondary antibodies have Fc regions that bind to Fc receptors expressed on macrophages, dendritic cells, and other immune cells present in tissue sections \u2014 generating non-specific signal independent of primary antibody binding.<\/li>\n
  2. Charge-based non-specific binding:<\/strong> IgG molecules are positively charged at physiological pH and can bind non-specifically to negatively charged tissue components (collagen, nucleic acids).<\/li>\n<\/ol>\n

    Blocking serum works by saturating Fc receptors and non-specific binding sites before the primary antibody is applied. The IgG in blocking serum occupies these sites \u2014 so when your secondary antibody arrives, specific binding sites on the primary antibody are the only available targets.<\/p>\n

    The species matching rule \u2014 the most important decision<\/h2>\n

    The blocking serum species must match the species in which your secondary antibody was raised \u2014 not the species in which your primary antibody was raised.<\/p>\n

    Example:<\/strong> Primary antibody = rabbit anti-human CD3 (raised in rabbit). Secondary antibody = donkey anti-rabbit IgG-AF488 (raised in donkey). Blocking serum = normal donkey serum<\/strong>.<\/p>\n

    The logic: your secondary antibody was raised in donkey and therefore cross-reacts with donkey IgG. If you block with donkey serum, the IgG in the blocking serum occupies non-specific sites. When the donkey secondary antibody arrives, it cannot bind to those sites because they are already occupied by matching donkey IgG.<\/p>\n

    If you use the wrong species for blocking (e.g. goat serum when your secondary is donkey anti-rabbit), the blocking serum IgG does not compete with the secondary antibody for non-specific binding sites \u2014 background remains high.<\/p>\n

    Species selection \u2014 which serum for which secondary<\/h2>\n\n\n\n\n\n\n\n\n\n
    Secondary antibody raised in<\/th>\nCorrect blocking serum<\/th>\nSeamlessBio product<\/th>\n<\/tr>\n
    Donkey<\/td>\nNormal Donkey Serum (NDS)<\/td>\nEsel-Serum<\/a><\/td>\n<\/tr>\n
    Ziege<\/td>\nNormal Goat Serum (NGS)<\/td>\nZiegenserum<\/a><\/td>\n<\/tr>\n
    Kaninchen<\/td>\nNormal Rabbit Serum (NRS)<\/td>\nKaninchenserum<\/a><\/td>\n<\/tr>\n
    Horse<\/td>\nNormal Horse Serum (NHS)<\/td>\nPferdeserum<\/a><\/td>\n<\/tr>\n
    Schaf<\/td>\nNormal Sheep Serum (NSS)<\/td>\nSchafserum<\/a><\/td>\n<\/tr>\n
    Chicken \/ Hen<\/td>\nNormal Chicken Serum (NCS)<\/td>\nH\u00fchnerserum<\/a><\/td>\n<\/tr>\n
    Meerschweinchen<\/td>\nNormal Guinea Pig Serum (NGPS)<\/td>\nMeerschweinchen-Serum<\/a><\/td>\n<\/tr>\n<\/table>\n

    Why donkey serum is increasingly the default<\/h2>\n

    Multi-label immunofluorescence \u2014 staining three or four antigens simultaneously with spectrally distinct fluorophores \u2014 requires secondary antibodies from different species to avoid cross-reactivity. If all your secondary antibodies are raised in donkey (donkey anti-rabbit, donkey anti-mouse, donkey anti-goat), you use a single blocking step with normal donkey serum. This simplifies the protocol and eliminates the species-switching errors common in multi-label setups.<\/p>\n

    The dominance of donkey-raised secondary antibodies from major suppliers (Jackson ImmunoResearch, Thermo Fisher) for multi-species cross-adsorbed panels has made normal donkey serum the most widely used blocking reagent in multi-label IHC and IF.<\/p>\n

    Standard blocking protocol<\/h2>\n
      \n
    1. After antigen retrieval and permeabilisation (if required), drain excess buffer \u2014 do not wash off<\/li>\n
    2. Apply blocking solution: 5\u201310% normal serum<\/strong> in PBS (or PBST for permeabilised cells) \u2014 200\u2013300 \u00b5L per section or well<\/li>\n
    3. Incubate 30\u201360 minutes<\/strong> at room temperature in humidified chamber<\/li>\n
    4. Do not wash<\/strong> \u2014 drain excess blocking solution by tilting the slide; residual blocking serum maintains non-specific site saturation during primary antibody incubation<\/li>\n
    5. Apply primary antibody diluted in the same blocking buffer<\/strong> (1\u20135% normal serum in PBS) \u2014 this maintains blocking conditions throughout primary antibody incubation<\/li>\n<\/ol>\n

      Heat inactivation \u2014 required or not?<\/h2>\n

      Heat inactivation (56\u00b0C, 30 min) destroys complement activity. For blocking applications in IHC and IF, heat inactivation is recommended when:<\/p>\n